Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-16T13:48:26.924Z Has data issue: false hasContentIssue false

Infection Control Considerations for In Vitro Fertilization and Embryo Transfer Programs

Published online by Cambridge University Press:  02 January 2015

Peter Axelrod*
Affiliation:
Infectious Diseases Section, University of Pennsylvania School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
George H. Talbot
Affiliation:
Infectious Diseases Section, University of Pennsylvania School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
*
Infection Control, 1-Gibson, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104

Extract

In vitro fertilization and embryo transfer (IVF-ET) is a process in which human ova are obtained by laparoscopic ovarian follicular puncture, fertilized in vitro by capacitated donor sperm, and introduced transcervically into the uterus. The prospective mother's ovarian cycle is usually stimulated with either clomiphene citrate, human menopausal gonadotropin, or both, so that multiple aspiratable follicles are produced. Follicular development is monitored by ultrasound and by serial serum or urine estrogen determinations. When adequate follicular development has been achieved, a pre-ovulatory dose of human chorionic gonadotropin is administered.

Information

Type
Special Sections
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable